GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

GRAIL (NASDAQ: GRAL), a healthcare company focused on early cancer detection, has announced the granting of equity awards to 27 newly hired non-executive employees.

Rhea-AI Summary

GRAIL (NASDAQ: GRAL), a healthcare company focused on early cancer detection, has announced the granting of equity awards to 27 newly hired non-executive employees. The awards consist of restricted stock units (RSUs) totaling 47,150 shares of GRAIL's common stock.

The RSUs were granted under GRAIL's Inducement Equity Incentive Plan in accordance with Nasdaq Listing Rule 5635(c)(4). The vesting schedule spans approximately four years, with 25% vesting on August 31, 2026, and the remaining portions vesting annually thereafter, contingent on continued employment.

Argus Sep 2 session

-3.60% close to close 0.8x rel. volume Open Argus

Details

News Market Reaction – GRAL

On Sep 2, the first trading day after this news, GRAL closed 3.60% below the previous close.

Data tracked by StockTitan Argus for the Sep 2 session.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

MENLO PARK, Calif., Aug. 29, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that it has granted equity awards in the form of restricted stock units ("RSUs") underlying an aggregate of 47,150 shares of GRAIL's common stock to 27 recently hired non-executive employees as an inducement material to their acceptance of employment with GRAIL. The employment inducement awards were granted under GRAIL's Inducement Equity Incentive Plan and related form of restricted stock award agreement in accordance with Nasdaq Listing Rule 5635(c)(4).

The inducement plan is used exclusively for the grant of equity awards to individuals who were not previously employees of GRAIL, or following a bona fide period of non-employment, as an inducement material to such individuals entering into employment with GRAIL, pursuant to Nasdaq Listing Rule 5635(c)(4).

The RSUs vest over an approximately four year period, with 25% of the award vesting Aug. 31, 2026, and on each one year anniversary of those respective dates thereafter, subject to continued employment with GRAIL (or any successor to or subsidiary of the Company) through the vesting dates.

About GRAIL
GRAIL is a healthcare company whose mission is to detect cancer early, when it can be cured. GRAIL is focused on alleviating the global burden of cancer by using the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. GRAIL's targeted methylation-based platform can support the continuum of care for screening and precision oncology, including multi-cancer early detection in symptomatic patients, risk stratification, minimal residual disease detection, biomarker subtyping, treatment and recurrence monitoring. GRAIL is headquartered in Menlo Park, CA with locations in Washington, D.C., North Carolina, and the United Kingdom.

For more information, visit grail.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/grail-announces-inducement-grants-under-nasdaq-listing-rule-5635c4-302542242.html

SOURCE GRAIL, Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What equity awards did GRAIL (NASDAQ: GRAL) announce on August 29, 2025?

GRAIL announced restricted stock units (RSUs) totaling 47,150 shares granted to 27 new non-executive employees as employment inducement awards.

How will the GRAIL RSUs vest for new employees?

The RSUs will vest over approximately four years, with 25% vesting on August 31, 2026, and the remaining portions vesting annually thereafter, subject to continued employment.

Under what plan were GRAIL's inducement grants issued?

The grants were issued under GRAIL's Inducement Equity Incentive Plan in accordance with Nasdaq Listing Rule 5635(c)(4).

Who is eligible for GRAIL's inducement equity awards?

The awards are exclusively for individuals who were not previously GRAIL employees or those following a bona fide period of non-employment, as an inducement to join the company.